» Articles » PMID: 36206976

Machine Learning Guided Structure Function Predictions Enable in Silico Nanoparticle Screening for Polymeric Gene Delivery

Overview
Journal Acta Biomater
Publisher Elsevier
Date 2022 Oct 7
PMID 36206976
Authors
Affiliations
Soon will be listed here.
Abstract

Developing highly efficient non-viral gene delivery reagents is still difficult for many hard-to-transfect cell types and, to date, has mostly been conducted via brute force screening routines. High throughput in silico methods of evaluating biomaterials can enable accelerated optimization and development of devices or therapeutics by exploring large chemical design spaces quickly and at low cost. This work reports application of state-of-the-art machine learning algorithms to a dataset of synthetic biodegradable polymers, poly(beta-amino ester)s (PBAEs), which have shown exciting promise for therapeutic gene delivery in vitro and in vivo. The data set includes polymer properties as inputs as well as polymeric nanoparticle transfection performance and nanoparticle toxicity in a range of cells as outputs. This data was used to train and evaluate several state-of-the-art machine learning algorithms for their ability to predict transfection and understand structure-function relationships. By developing an encoding scheme for vectorizing the structure of a PBAE polymer in a machine-readable format, we demonstrate that a random forest model can satisfactorily predict DNA transfection in vitro based on the chemical structure of the constituent PBAE polymer in a cell line dependent manner. Based on the model, we synthesized PBAE polymers and used them to form polymeric gene delivery nanoparticles that were predicted in silico to be successful. We validated the computational predictions in two cell lines in vitro, RAW 264.7 macrophages and Hep3B liver cancer cells, and found that the Spearman's R correlation between predicted and experimental transfection was 0.57 and 0.66 respectively. Thus, a computational approach that encoded chemical descriptors of polymers was able to demonstrate that in silico computational screening of polymeric nanomedicine compositions had utility in predicting de novo biological experiments. STATEMENT OF SIGNIFICANCE: Developing highly efficient non-viral gene delivery reagents is difficult for many hard-to-transfect cell types and, to date, has mostly been explored via brute force screening routines. High throughput in silico methods of evaluating biomaterials can enable accelerated optimization and development for therapeutic or biomanufacturing purposes by exploring large chemical design spaces quickly and at low cost. This work reports application of state-of-the-art machine learning algorithms to a large compiled PBAE DNA gene delivery nanoparticle dataset across many cell types to develop predictive models for transfection and nanoparticle cytotoxicity. We develop a novel computational pipeline to encode PBAE nanoparticles with chemical descriptors and demonstrate utility in a de novo experimental context.

Citing Articles

Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines.

Liu M, Wang Y, Zhang Y, Hu D, Tang L, Zhou B Signal Transduct Target Ther. 2025; 10(1):73.

PMID: 40059188 PMC: 11891339. DOI: 10.1038/s41392-024-02112-8.


Developing mRNA Nanomedicines with Advanced Targeting Functions.

Wang J, Cai L, Li N, Luo Z, Ren H, Zhang B Nanomicro Lett. 2025; 17(1):155.

PMID: 39979495 PMC: 11842722. DOI: 10.1007/s40820-025-01665-9.


Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches.

Maharjan R, Kim K, Lee K, Han H, Jeong S J Pharm Anal. 2025; 14(11):100996.

PMID: 39759971 PMC: 11696778. DOI: 10.1016/j.jpha.2024.100996.


Machine Learning Elucidates Design Features of Plasmid Deoxyribonucleic Acid Lipid Nanoparticles for Cell Type-Preferential Transfection.

Cheng L, Zhu Y, Ma J, Aggarwal A, Toh W, Shin C ACS Nano. 2024; 18(42):28735-28747.

PMID: 39375194 PMC: 11512640. DOI: 10.1021/acsnano.4c07615.


The Dawn of a New Pharmaceutical Epoch: Can AI and Robotics Reshape Drug Formulation?.

Bannigan P, Hickman R, Aspuru-Guzik A, Allen C Adv Healthc Mater. 2024; 13(29):e2401312.

PMID: 39155417 PMC: 11582498. DOI: 10.1002/adhm.202401312.


References
1.
Bishop C, Ketola T, Tzeng S, Sunshine J, Urtti A, Lemmetyinen H . The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. J Am Chem Soc. 2013; 135(18):6951-7. PMC: 3838887. DOI: 10.1021/ja4002376. View

2.
Eltoukhy A, Siegwart D, Alabi C, Rajan J, Langer R, Anderson D . Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity. Biomaterials. 2012; 33(13):3594-603. PMC: 3326358. DOI: 10.1016/j.biomaterials.2012.01.046. View

3.
Bulaklak K, Gersbach C . The once and future gene therapy. Nat Commun. 2020; 11(1):5820. PMC: 7670458. DOI: 10.1038/s41467-020-19505-2. View

4.
Rui Y, Wilson D, Choi J, Varanasi M, Sanders K, Karlsson J . Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing. Sci Adv. 2019; 5(12):eaay3255. PMC: 6897553. DOI: 10.1126/sciadv.aay3255. View

5.
Wu Z, Kan S, Lewis R, Wittmann B, Arnold F . Machine learning-assisted directed protein evolution with combinatorial libraries. Proc Natl Acad Sci U S A. 2019; 116(18):8852-8858. PMC: 6500146. DOI: 10.1073/pnas.1901979116. View